<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
      <JournalTitle>Journal of International Medical Research and Health Sciences</JournalTitle>
      <Volume-Issue>Volume 1 Issue 2</Volume-Issue>
      <Season>(Jul-Sept, 2021)</Season>
      <ArticleTitle>Anti-Leishmanial drug Pentostam induced histological changes to liver and kidney in male BALB/c wild mice</ArticleTitle>
          <FirstName>Nouara Elazirg</FirstName>
          <FirstName>Salem Ramadan</FirstName>
      <Abstract>Leishmaniasis is still a complex disease of (sub) tropical regions of the world caused by Leishmania spp. Antimonial pentostam is an anti-leishmaniasis drug used medically and it is the primary drug employed against leishmaniasis in Libya. It has multiple acute and chronic adverse effects which can be minimized by using the lowest effective dose. This work aimed to investigate the histological changes in the liver and kidneys affected by different doses of pentostam. Adult male of BALB/c wild mice was divided into four groups, 6 mice of each, and i.p. injected with 10mg/kg, 20mg/kg, and 40mg/kg pentostam in addition to a control group. After 28 therapeutic days and finishing the histological procedure to examine the collected tissue specimens, the obtained results of the liver tissue ranged from demonstrating cytoplasmic vacuoles, to hydropic degeneration, focal and hepatocytic necrosis, and lastly irregular area of hepatocytes with condensed pyknotic nuclei (hepatocyte necrosis). As well, the histological examination of kidney tissue ranged between demonstrating mild cloudy swelling (reversible hydropic degeneration), showed stromal aggregates of inflammatory cells (nephritis), and lastly showed renal tubule casts and necrosis. In a final conclusion, there are clear histological changes in the liver and kidneys, which had been seen in this study, which are dose-dependent changes.</Abstract>
      <Keywords>leishmaniasis, anti leishmaniasis drug, pentostam, histological examination of liver tissue, histological examination of kidney tissue</Keywords>
        <Abstract>https://www.jimrhs.com/ubijournal-v1copy/journals/abstract.php?article_id=13526&amp;title=Anti-Leishmanial drug Pentostam induced histological changes to liver and kidney in male BALB/c wild mice</Abstract>
        <References>[1] Abyot Desta, Solomon Shiferaw, Andargachew Kassa, Techalew Shimelis, and Simachew Dires. Leishmaniasis for the Ethiopian Health Center Team. EPHTI, 2005.&#13;
[2] Afshar S., AA Farshid, R Heidari and M Ilkhanipour. Histopathological changes in the liver and kidney tissues of Wistar albino rat exposed to fenitrothion. Toxicology and Industrial Health 2008; 24: 581–586.&#13;
[3] Al-Jahdali, MO, Bin Bisher, AS Abu zeid, IM (2007) Physiological and histological alterations in rats liver induced by sumithion® NP 25/2.5 EC, an insecticide used in Dengue Fever Vector control in Jeddah Saudi Arabia. Saudi J Biol Sci 14: 43–51.&#13;
[4] Finn, WF. Renal responses to environmental toxins. Environ Health Perspect (1977) 20: 15–26.&#13;
[5] Furhan Iqbal, Irfan Zia Qureshi and Muhammad Ali. Histopathological Changes in the kidney of common carp, Cyprinus carpio, following nitrate exposure. J. res. Sci., 2004, 15(4), 411-418.&#13;
[6] Garc? ´a-Herna ´ndez R, Manzano JI, Castanys S, Gamarro F. Leishmania donovani develops resistance to drug combinations. PLoS Negl Trop Dis. 2012; 6(12):e1974.&#13;
[7] Hole, J. W. “Essentials of human anatomy and physiology”, (1992) 4th ed. Wm. C. Brown Publishers, Dubuque, 745- 749.&#13;
[8] Ludwig J, Moyer TP, Rakela J. The liver biopsy diagnosis of Wilsonand;#39;s disease. Methods in pathology. Am J Clin Pathol 1994; 102:443–6.&#13;
[9] Mitropoulos P, Konidas P, Durkin-Konidas M. New World cutaneous leishmaniasis: updated review of current and future diagnosis and treatment. J Am Acad Dermatol. 2010; 63(2):309–22.&#13;
[10] Ponte-Sucre Alicia, Francisco Gamarro, Jean-Claude Dujardin, Michael P. Barrett, Rogelio Lo ´pez-Ve ´lez, Raquel Garc ´a-Herna ´ndez, Andrew W. Pountain, Roy Mwenechanya, Barbara Papadopoulou. Drug resistance and treatment failure in leishmaniasis: A 21st-century challenge. PLOS Neglected Tropical Diseases. December 14, 2017.&#13;
[11] Roganovic-Zafirova, D, Jordanova, M. Liver lesions in bleak (Alhurnus alburnus alborella Filippi) collected from some contaminated sites on lake Ohrid. A histopathological evidence. Ekol Zast Zivot Sred (1998) 6: 11–18.&#13;
[12] Shahrbaf Fatemeh Ghane, Farahnak Assadi. Drug-induced renal disorders. J Renal Inj Prev. 2015; 4(3): 57-60.&#13;
[13] Torbenson M. Biopsy interpretation of the liver. Wolters Kluwer Health, 2014.&#13;
[14] WHO http://apps.who.int/iris/handle/10665/255104. Accessed on 10 May 2017.</References>